The Scientist - Home

Emmanuelle Charpentier and Jennifer Doudna reprogrammed the bacterial immune response into one of the most popular tools for genetics and molecular biology.

Overactive immune cells identified in a mouse model and in postmortem human brain tissue may offer a potential therapeutic target for cognitive delays associated with the condition, researchers report.

Marine ecologist Jeroen Ingels discusses what is known about ice shelf loss at the southern pole and how those changes are affecting local ecosystems.

The President was hospitalized on Friday evening and has been receiving an aggressive treatment of experimental and standard drugs.

Harvey Alter, Michael Houghton, and Charles Rice share the Physiology or Medicine award for their contributions to identifying the virus and demonstrating that it was responsible for hepatitis among blood transfusion recipients.

As the hiring season gets underway, academic listings are still way down from last year, but there are signs of the job market picking back up.

The results add to mounting evidence of microbes’ roles in tumor growth and point to the possibility of impeding malignancies by inhibiting bacteria.

Almost 60 percent of people in a new study on attitudes in the US felt comfortable using animals to grow human organs from induced pluripotent stem cells.

Tiny doses of maternal poo mixed with breast milk and given to Cesarean-born infants makes their gut microbiota resemble those of babies born vaginally.

Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.

In the past, it was not uncommon for researcher to test their experimental therapeutics and vaccines on themselves. Some even volunteered to be exposed to pathogen-carrying vectors.

The primordial emotion is apt to run amok. But harnessing it can lead to responsible behavior and sound thinking.